NBC News
@NBCNews·11.9M subscribers·98K videos
FDA grants first ever approval for Alzheimer’s drug meant to slow disease
Posted
July 6, 2023
Views
10,091
Likes
171
Comments
47
Engagement
2.16%
July 6, 2023
10,091
171
47
2.16%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:17Now PlayingThe Food and Drug Administration fully approved the Alzheimer’s drug Leqembi, meant to slow development of the disease. Treatment costs $26,500 per year and is only approved for people in the early stages of Alzheimer's.
» Subscribe to NBC News
» Watch more NBC video
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App
Breaking News Alerts
Visit NBCNews.Com
Find NBC News on Facebook
Follow NBC News on Twitter
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters
#Alzheimers #Health #Drug
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
